198 Topics in Current Chemistry Editorial Board: A. de Meijere KN ...
198 Topics in Current Chemistry Editorial Board: A. de Meijere KN ...
198 Topics in Current Chemistry Editorial Board: A. de Meijere KN ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Crystall<strong>in</strong>e Polymorphism of Organic Compounds 165<br />
control <strong>in</strong> polymorphism is briefly addressed with a view to illustrat<strong>in</strong>g current<br />
strategies and their implications for the <strong>de</strong>sign of solids.<br />
2<br />
Crystal Polymorphism – Theoretical Pr<strong>in</strong>ciples and Practical Implications<br />
2.1<br />
Background – The Role of Polymorphism <strong>in</strong> the Production of Materials<br />
Many of the <strong>in</strong>consistencies encountered <strong>in</strong> product performance <strong>in</strong> the chemical,<br />
chemical eng<strong>in</strong>eer<strong>in</strong>g, pharmaceutical, food and related <strong>in</strong>dustries can be<br />
attributed to polymorphism.An important example is <strong>in</strong>consistent behaviour of<br />
drug substances upon dissolution which may have a direct <strong>in</strong>fluence on bioavailability.<br />
This arises because different polymorphic forms of the same drug may<br />
have solubilities which differ by an or<strong>de</strong>r of magnitu<strong>de</strong> [24]. Inadvertent<br />
production of the ‘wrong’ polymorph at the crystallization stage follow<strong>in</strong>g synthesis<br />
or at any of the <strong>in</strong>termediate process<strong>in</strong>g stages can therefore result <strong>in</strong><br />
pharmaceutical dosage forms which are either <strong>in</strong>effective or toxic [37, 38]. Spontaneous<br />
polymorphic transformations mediated by solvents is common [4] and<br />
liquid preparations of metastable drugs frequently lose their effectiveness due<br />
to precipitation of less soluble, thermodynamically more stable polymorphs or<br />
pseudopolymorphs. A case <strong>in</strong> po<strong>in</strong>t is the antiprotozoal agent metronidazole<br />
benzoate which, when stored as an aqueous suspension below 38 °C is metastable,<br />
lead<strong>in</strong>g to precipitation and growth of the <strong>in</strong>soluble monohydrate<br />
[39, 40].<br />
Dunitz and Bernste<strong>in</strong> [5] have recently documented several cases of “vanish<strong>in</strong>g”<br />
polymorphs. These are usually metastable forms which, <strong>de</strong>spite their<br />
thermodynamic <strong>in</strong>stability, may have crystallized preferentially due to more<br />
rapid nucleation. Such metastable forms may persist and be used for many years<br />
before be<strong>in</strong>g “displaced”, when a thermodynamically more stable form is prepared.<br />
Attempts to regenerate the orig<strong>in</strong>al polymorph are frequently met with<br />
failure. Specific compounds with such a history <strong>in</strong>clu<strong>de</strong> e.g. 1,2,3,5-tetra-<br />
O-acetyl-b-D-ribofuranose, benzoca<strong>in</strong>e picrate and xylitol. This disturb<strong>in</strong>g<br />
phenomenon extends to pseudopolymorphs. A previously known monohydrate<br />
of the antibiotic ampicill<strong>in</strong> has not been obta<strong>in</strong>ed s<strong>in</strong>ce the appearance of the<br />
trihydrate [24]. A possible explanation for this behaviour is that after m<strong>in</strong>ute<br />
particles of the stable polymorph enter the environment, they eventually become<br />
wi<strong>de</strong>ly dissem<strong>in</strong>ated (“planetary seed<strong>in</strong>g” [5]) and serve as nuclei promot<strong>in</strong>g<br />
crystallization of their own k<strong>in</strong>d exclusively.<br />
Manufactur<strong>in</strong>g processes <strong>in</strong>clud<strong>in</strong>g crystallization scale-up, dry<strong>in</strong>g, heat<strong>in</strong>g,<br />
compression and mill<strong>in</strong>g can <strong>in</strong>duce polymorphic transformations [24] and it<br />
follows that careful quality control is necessary at all stages to monitor un<strong>de</strong>sirable<br />
changes. Systematic <strong>in</strong>vestigation of a compound to <strong>de</strong>term<strong>in</strong>e whether it is<br />
prone to polymorphism, as well as the nature of the polymorphism (enantiotropic<br />
or monotropic) [23], is rout<strong>in</strong>e practice <strong>in</strong> pharmaceutical pre-formulation<br />
studies. I<strong>de</strong>ntification of the different polymorphic forms of a drug substance,<br />
<strong>de</strong>term<strong>in</strong>ation of their chemical and physical properties, thermodynamic